Fei Zhao

机构：China National Pharmaceutical Group Corporation (China), Baosteel (China), Shanghai Institute of Pharmaceutical Industry · ORCID：0000-0002-2149-1457

发表论文 69 篇 · 总被引 4780 次 · h-index 27

代表论文

• AMPK-mediated activation of MCU stimulates mitochondrial Ca2+ entry to promote mitotic progression (2019 · Nature Cell Biology · 被引 159)
• Stromal Fibroblasts Mediate Anti–PD-1 Resistance via MMP-9 and Dictate TGFβ Inhibitor Sequencing in Melanoma (2018 · Cancer Immunology Research · 被引 120)
• DPF2 reads histone lactylation to drive transcription and tumorigenesis (2024 · Proceedings of the National Academy of Sciences · 被引 106)
• MET Amplification Attenuates Lung Tumor Response to Immunotherapy by Inhibiting STING (2021 · Cancer Discovery · 被引 83)
• TTC36 inactivation induce malignant properties via Wnt-β-catenin pathway in gastric carcinoma (2021 · Journal of Cancer · 被引 30)
• Neutrophil extracellular traps increased by hyperglycemia exacerbate ischemic brain damage (2020 · Neuroscience Letters · 被引 30)